Renal Business Today

Clinical & Pharma

Kidney disease patients rely on numerous pharmaceuticals—including erythropoiesis-stimulating agents (ESAs),iron, Vitamin D, phosphate binders and calcium—to ensure proper care. In addition, new clinical research is released on a regular basis by nephrologists and other doctors to advance the field of nephrology.

Informed Patients More Likely To Get Transplant

ORLANDO, Fla.—The more you know the better your chances of making good decisions in life and your health and what you don't know can hurt your chances of getting a transplant. ...More
April 3, 2013
Posted in News, Clinical & Pharma
Lifestyle Linked with Longer Survival Among Kidney Patients

WASHINGTON—Certain lifestyle factors—such as not smoking, getting regular physical activity, and avoiding a low body weight—may help prolong the lives of individuals with chronic kidney disease (CKD), according to a study appearing in the April issue of the Clinical Journal ...More
March 26, 2013
Posted in News, Clinical & Pharma
Protein in Urine Linked to Life Expectancy

NEW YORK—The levels of protein in the urine, also known as proteinuria, and mortality have been linked in a new study published in the American Journal of Kidney Diseases. ...More
March 21, 2013
Posted in News, Clinical & Pharma
Potential Early Indicator of Kidney Injury Identified

AUGUSTA, Ga.—A guidance cue that helps kidneys form may also be a red flag that they are in danger, researchers report. ...More
March 12, 2013
Posted in Articles, Clinical & Pharma
Fewer Transplants Done Through Kidney Chains

BALTIMORE—An additional 1,000 patients could undergo kidney transplants in the United States annually if hospitals performed more transplants using paired kidney exchanges, new Johns Hopkins research suggests. ...More
March 12, 2013
Posted in Articles, Clinical & Pharma
Management of Anemia in Children on Dialysis Examined

WASHINGTON —Children on dialysis who have anemia and who require high doses of drugs to treat it have an increased risk of dying prematurely, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings ...More
March 8, 2013
Posted in News, Clinical & Pharma
Deleting Gene in Mice Eliminates Obesity

AURORA, Colo.—Researchers have discovered that deleting a specific gene in mice prevents them from becoming obese even on a high fat diet, a finding they believe may be replicated in humans. ...More
March 5, 2013
Posted in News, Clinical & Pharma
Saying Goodbye to Anti-Rejection Drugs

One knows that when a person gets a kidney transplant they are required to take anti-rejection medication for as long as the kidney continues to work. Anti-rejection medication is necessary in order for the foreign object, the kidney, to be accepted by the body. ...More
March 5, 2013
Posted in Articles, Clinical & Pharma, Practice Management
New Cause for Organ Rejection Identified

MONTREAL— A team led by Dr. Marie-Josée Hébert from the University of Montreal Hospital Research Centre (CRCHUM) has discovered a new cause of organ rejection in some kidney transplant patients. Her team has identified a new class of antibodies —anti-LG3—which when ...More
February 28, 2013
Posted in News, Clinical & Pharma
Reprogramming Cells to Fight Diabetes

PHILADELPHIA – For years researchers have been searching for a way to treat diabetics by reactivating their insulin-producing beta cells, with limited success. The "reprogramming" of related alpha cells into beta cells may one day offer a novel and complementary approach ...More
February 26, 2013
Posted in News, Clinical & Pharma